MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES
<p>At present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the component...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/471 |
id |
doaj-598c7cf3ea1d48b4b7eef80cfa46d88c |
---|---|
record_format |
Article |
spelling |
doaj-598c7cf3ea1d48b4b7eef80cfa46d88c2020-11-24T22:55:58ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-018346346810.1234/1819-6446-2012-3-463-468471MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASESA. V. Govorin0A. P. Filev1Читинская государственная медицинская академияЧитинская государственная медицинская академия<p>At present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the components contributing to its intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid that contributes to intracellular penetration. Data of some studies on magnesium-containing drugs application in different cardiovascular diseases are presented.</p>http://www.rpcardio.ru/jour/article/view/471магнийоротат магниямагнеротсердечно-сосудистая система |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. V. Govorin A. P. Filev |
spellingShingle |
A. V. Govorin A. P. Filev MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Racionalʹnaâ Farmakoterapiâ v Kardiologii магний оротат магния магнерот сердечно-сосудистая система |
author_facet |
A. V. Govorin A. P. Filev |
author_sort |
A. V. Govorin |
title |
MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
title_short |
MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
title_full |
MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
title_fullStr |
MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
title_full_unstemmed |
MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES |
title_sort |
magnesium-containing drugs in cardiovascular diseases |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-12-01 |
description |
<p>At present experimental and clinical data confirming efficacy of magnesium-containing drugs in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its intracellular fraction. That is why it is desirable to use magnesium with the components contributing to its intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid that contributes to intracellular penetration. Data of some studies on magnesium-containing drugs application in different cardiovascular diseases are presented.</p> |
topic |
магний оротат магния магнерот сердечно-сосудистая система |
url |
http://www.rpcardio.ru/jour/article/view/471 |
work_keys_str_mv |
AT avgovorin magnesiumcontainingdrugsincardiovasculardiseases AT apfilev magnesiumcontainingdrugsincardiovasculardiseases |
_version_ |
1725655502974615552 |